Market Overview

Benzinga's Top Downgrades

Related ATU
Earnings Scheduled For June 17, 2015
What's Coming For Actuant?
Related XYL
Mario Gabelli Betting Big On This Water Industry Stock
Nelson Peltz And Pentair: Could M&A Be On The Horizon?
Xylem's (XYL) CEO Patrick Decker on Q2 2015 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

Jun 2015BMO CapitalMaintainsMarket Perform
Jun 2015RBC CapitalUpgradesSector PerformOutperform
Mar 2015Stifel NicolausDowngradesBuyHold

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ATU + ANTH)

Get Benzinga's Newsletters